MBNL1 and retinoblastoma: In retinoblastoma, LncRNA MBNL1‐AS1 can inhibit the Wnt/β‐catenin signaling pathway to exert antitumor effect, and the pathway inhibition needs to be achieved by targeting miR‐338‐5p through MBNL1‐AS1.221